Yang Yang, Hao Yan, Huang Xianli, Ran Maoxia, Liu Chen, Liu Zhuang, Chen Yu, Zhang Ling
{"title":"Niagara<sup>@</sup> catheter equipped with a novel helical flow inducer to improve hemodynamic performance.","authors":"Yang Yang, Hao Yan, Huang Xianli, Ran Maoxia, Liu Chen, Liu Zhuang, Chen Yu, Zhang Ling","doi":"10.3389/fbioe.2025.1545996","DOIUrl":null,"url":null,"abstract":"<p><p>Hemodialysis is an important means to sustain life in patients with end-stage renal disease In China, more than 100,000 hemodialysis patients need to have a catheter fitted at least once (temporary or long term) for dialysis. Despite the widespread use and low cost of HD catheters, they remain prone to critical issues such as high thrombosis rates, infections, and dysfunction. This study addresses the persistent challenge of thrombosis formation in dialysis catheters by investigating the incorporation of helical flow inducers, a strategy inspired by the naturally occurring helical blood flow in arterial systems. In this research, helical flow inducers with varying pitch and diameter were integrated into the widely used Niagara<sup>@</sup> catheter. Computational fluid dynamics simulations were conducted to evaluate the impact on key parameters such as local normalized helicity (LNH), residence time (RT), shear stress, and flow velocity. The results demonstrated that 1) small-diameter inducers produce helical flow. Among inducers with identical diameter, those with a smaller thread pitch are more likely to induce increased LNH; 2) a small thread pitch helical flow inducer reduced the percentage of blood volume, with RT exceeding 0.015 s from 40.8% in the control to 12.7%, suggesting a substantial reduction in thrombosis risk; 3) the study also found that the introduction of small thread pitch helical flow inducers led to increased shear stress, with Model A showing an average shear stress of 49.2 Pa, compared to 32.0 Pa in the control. This highlights the need for careful optimization to balance the benefits of reduced thrombosis risk with the potential for shear-induced hemolysis. In conclusion, the integration of helical flow inducers into dialysis catheters offers a promising strategy for improving intraluminal flow dynamics and reducing the risk of thrombosis.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1545996"},"PeriodicalIF":4.3000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11966438/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1545996","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Hemodialysis is an important means to sustain life in patients with end-stage renal disease In China, more than 100,000 hemodialysis patients need to have a catheter fitted at least once (temporary or long term) for dialysis. Despite the widespread use and low cost of HD catheters, they remain prone to critical issues such as high thrombosis rates, infections, and dysfunction. This study addresses the persistent challenge of thrombosis formation in dialysis catheters by investigating the incorporation of helical flow inducers, a strategy inspired by the naturally occurring helical blood flow in arterial systems. In this research, helical flow inducers with varying pitch and diameter were integrated into the widely used Niagara@ catheter. Computational fluid dynamics simulations were conducted to evaluate the impact on key parameters such as local normalized helicity (LNH), residence time (RT), shear stress, and flow velocity. The results demonstrated that 1) small-diameter inducers produce helical flow. Among inducers with identical diameter, those with a smaller thread pitch are more likely to induce increased LNH; 2) a small thread pitch helical flow inducer reduced the percentage of blood volume, with RT exceeding 0.015 s from 40.8% in the control to 12.7%, suggesting a substantial reduction in thrombosis risk; 3) the study also found that the introduction of small thread pitch helical flow inducers led to increased shear stress, with Model A showing an average shear stress of 49.2 Pa, compared to 32.0 Pa in the control. This highlights the need for careful optimization to balance the benefits of reduced thrombosis risk with the potential for shear-induced hemolysis. In conclusion, the integration of helical flow inducers into dialysis catheters offers a promising strategy for improving intraluminal flow dynamics and reducing the risk of thrombosis.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.